What’s New in Gene Therapy? FDA Approves a First

Fresh insights, bold science, and global momentum—this edition delivers a snapshot of the early-phase clinical trial landscape across Latin America and Australia. From regulatory moves to first-in-human milestones, here’s what’s shaping the future of Medtech and Biopharma research:

first-in-human · clinical trial · regulatory · gene therapy · FDA · MedTech

Fresh insights, bold science, and global momentum—this edition delivers a snapshot of the early-phase clinical trial landscape across Latin America and Australia. From regulatory moves to first-in-human milestones, here’s what’s shaping the future of Medtech and Biopharma research:

A landmark gene therapy approval reshapes rare disease treatment. A digital therapeutic enters the ADHD space with clinical backing. Romania’s regulatory path decoded for faster study start-up. First-in-human ALS data reveals early biomarker activity.

Explore what’s new—and what it means for your next study. 👇

← All Global Trial Accelerators editions · Contact bioaccess®